Il libro è attualmente esaurito
Maggiori informazioni sul libro
The book presents a groundbreaking strategy for complete cancer treatment through two novel drug compounds, PT162 and PT167, developed by Andreas J. Kesel. These drugs target the Warburg effect, exploiting cancer's reliance on glycolysis due to mitochondrial dysfunction. Both compounds demonstrate significant efficacy in vitro against 60 cancer cell lines, inducing apoptosis by reactivating p53 and disrupting cyclin D1 regulation. The book details the chemistry behind these compounds and their apoptotic mechanisms, offering hope for innovative cancer therapies.
Acquisto del libro
THE POTENTIAL HEALING OF CANCER WITH P53 (RE)ACTIVATORS, Andreas Johannes Kesel
- Lingua
- Pubblicato
- 2023
- product-detail.submit-box.info.binding
- (Copertina rigida)
Ti avviseremo via email non appena lo rintracceremo.
Metodi di pagamento
Ancora nessuna valutazione.
- Titolo
- THE POTENTIAL HEALING OF CANCER WITH P53 (RE)ACTIVATORS
- Sottotitolo
- TWO NEW DRUGS EXPLOITING CANCER'S WARBURG EFFECT
- Lingua
- Inglese
- Autori
- Andreas Johannes Kesel
- Editore
- tredition
- Pubblicato
- 2023
- Formato
- Copertina rigida
- Pagine
- 264
- ISBN10
- 3384003128
- ISBN13
- 9783384003126
- Serie
- Tag
- Salute & Medicina, Natura, Scienze Naturali, Medicina, Chimica, Natura, animali, Farmacologia, Biochimica, Oncologia, Chimica organica, Biologia Molecolare, Biologia umana, Chimica Inorganica, Chemioterapia, Farmacoterapia
- Descrizione
- The book presents a groundbreaking strategy for complete cancer treatment through two novel drug compounds, PT162 and PT167, developed by Andreas J. Kesel. These drugs target the Warburg effect, exploiting cancer's reliance on glycolysis due to mitochondrial dysfunction. Both compounds demonstrate significant efficacy in vitro against 60 cancer cell lines, inducing apoptosis by reactivating p53 and disrupting cyclin D1 regulation. The book details the chemistry behind these compounds and their apoptotic mechanisms, offering hope for innovative cancer therapies.